Introducing Flow FL-100
FDA approved prescription treatment
Flow FL-100 is not yet available in the US. Sign up to learn more about Flow FL-100 and stay informed.
What is Flow FL-100 ?
Flow FL-100 is an at-home depression treatment that combines:
-
A lightweight headset to treat depression
-
A corresponding app to support the treatment
Flow FL-100 is prescribed and overseen by a qualified healthcare professional.
Who Flow FL-100 is for
Flow FL-100 is designed for:
-
Adults (18+) diagnosed with moderate to severe Major Depressive Disorder
-
Patients receiving care from a prescribing clinician
Only a healthcare professional can determine whether Flow FL-100 is appropriate for an individual patient.
Flow is supported by a randomised controlled trial published in Nature Medicine and is already used in routine clinical care across the UK and EU, with more than 55,000 patients treated in real-world settings to date2.
When will Flow FL-100 be available?
Flow FL-100 is expected to be available in the United States in summer 2026.
Access will be through a prescribing clinician.
Sign up to stay informed.
Only a healthcare professional can determine whether Flow FL-100 is appropriate for an individual patient.
Indication
Flow FL-100 is intended for the treatment of moderate to severe major depressive disorder (MDD) in the current episode, either as monotherapy or as an adjunctive treatment, in patients 18 years and older who are not considered treatment refractory to medication.
Safety information
The side effects of the Flow FL-100 reported in clinical studies were generally mild and transient. The main risks of the device are skin dryness, skin irritation or redness after prolonged use, transient headache, stinging, burning, or itching sensations at the stimulation site, and skin burns (typically in cases of electrode pad reuse or use of dried-out electrode pads which is not recommended). Full safety information here.
© 2026 Flow Neuroscience